Two populations of CD56 (Leu-19)+/CD16+ cells in bone marrow transplant recipients.

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Two populations of CD56 (Leu-19)+/CD16+ cells in bone marrow transplant recipients.

Bone marrow transplantation - 1 Apr 1990

Gottschalk L R, Bray R A, Kaizer H, Gebel H M

Abstract excerpt

Bone marrow transplant (BMT) recipients are severely immunocompromised during the early post-transplant period as their immune systems recapitulate. Among the first cells to repopulate the peripheral blood are natural killer (NK) cells. Studies in normal subjects have revealed that the majority o...

Topics

Adolescent
Adult
Antigens, Differentiation
Antigens, Differentiation, T-Lymphocyte
Antigens, Surface
Bone Marrow Transplantation
CD56 Antigen
Child
Female
Humans
Immune System
Interleukin-2
Killer Cells, Lymphokine-Activated
Killer Cells, Natural
Leukocytes, Mononuclear
Lymphocytes
Male
Phenotype

Source

Open in PubMed

Identifiers

PMID: 1692496

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-1692496-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics